{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:34:07Z","timestamp":1773308047503,"version":"3.50.1"},"publisher-location":"Berlin, Heidelberg","reference-count":48,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642303302","type":"print"},{"value":"9783642303319","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T00:00:00Z","timestamp":1344988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T00:00:00Z","timestamp":1344988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-3-642-30331-9_9","type":"book-chapter","created":{"date-parts":[[2012,8,14]],"date-time":"2012-08-14T14:58:59Z","timestamp":1344956339000},"page":"157-183","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Genetics, Inheritance and Strategies for Prevention in Populations at High Risk of Colorectal Cancer (CRC)"],"prefix":"10.1007","author":[{"given":"John","family":"Burn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Mathers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Tim","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,15]]},"reference":[{"key":"9_CR1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/328614a0","volume":"328","author":"WF Bodmer","year":"1987","unstructured":"Bodmer WF, Bailey CJ et al (1987) Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328: 614","journal-title":"Nature"},{"key":"9_CR49","first-page":"5248","volume":"58","author":"CR Boland","year":"1998","unstructured":"Boland CR, Thibodeau SN et al (1998) The international workshop on microsatellite instability and rer phenotypes in cancer detection and familial predisposition. Cancer Research 58:5248\u20135257","journal-title":"Cancer Research"},{"key":"9_CR2","unstructured":"Boland CR, Thibodeau SN et al (1997) The international workshop on microsatellite instability and rer phenotypes in cancer detection and familial predisposition: 1\u201335"},{"issue":"5","key":"9_CR4","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1158\/1940-6207.CAPR-11-0106","volume":"4","author":"J Burn","year":"2011a","unstructured":"Burn J, Bishop DT et al (2011a) A randomized placebo-controlled prevention trial of aspirin and\/or resistant starch in young people with familial adenomatous polyposis. Cancer Prev Res (Phila) 4(5):655\u2013665","journal-title":"Cancer Prev Res (Phila)"},{"key":"9_CR50","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/S0140-6736(11)61049-0","volume":"378","author":"J Burn","year":"2011","unstructured":"Burn J, Gerdes AM et al (2011b) Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 378:2081\u20132087","journal-title":"Lancet"},{"issue":"24","key":"9_CR5","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1056\/NEJMoa0801297","volume":"359","author":"J Burn","year":"2008","unstructured":"Burn J, Bishop DT et al (2008) Effect of aspirin or resistant starch on colorectal neoplasia in the lynch syndrome. N Engl J Med 359(24):2567\u20132578","journal-title":"N Engl J Med"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/jmg.28.5.289","volume":"28","author":"J Burn","year":"1991","unstructured":"Burn J, Chapman P et al (1991) The UK Northern Region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations. J Med Genet 28:289\u2013296","journal-title":"J Med Genet"},{"key":"9_CR7","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/bjc.1994.181","volume":"69","author":"A Cassidy","year":"1994","unstructured":"Cassidy A, Bingham SA et al (1994) Starch intake and colorectal cancer risk: an international comparison. Br J Cancer (London) 69:937\u2013942","journal-title":"Br J Cancer (London)"},{"key":"9_CR8","unstructured":"Chan AT, Arber N et al (2011) Aspirin in the chemoprevention of colorectal neoplasia: an overview. Cancer Prev Res (Phila)"},{"key":"9_CR9","unstructured":"Clark S (ed) (2009) A guide to cancer genetics in clinical practice, tfm Publishing Ltd"},{"issue":"4","key":"9_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jnci\/djn485","volume":"101","author":"BF Cole","year":"2009","unstructured":"Cole BF, Logan RF et al (2009) Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst 101(4):256\u2013266","journal-title":"J Natl Cancer Inst"},{"key":"9_CR11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1053\/gast.2002.31890","volume":"122","author":"M Cruz-Correa","year":"2002","unstructured":"Cruz-Correa M, Hylind LM et al (2002) Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Gastroenterology 122: 641\u2013645","journal-title":"Gastroenterology"},{"issue":"5","key":"9_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S1470-2045(09)70035-X","volume":"10","author":"J Cuzick","year":"2009","unstructured":"Cuzick J, Otto F et al (2009) Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol 10(5):501\u2013507","journal-title":"Lancet Oncol"},{"issue":"10","key":"9_CR13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrc1453","volume":"4","author":"A Chapelle","year":"2004","unstructured":"de la Chapelle A (2004) Genetic predisposition to colorectal cancer. Nat Rev Cancer 4(10): 769\u2013780","journal-title":"Nat Rev Cancer"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1136\/jmg.9.4.451","volume":"9","author":"GH Dunstone","year":"1972","unstructured":"Dunstone GH, Knaggs TWL (1972) Familial cancer of the colon and rectum. J Med Genet 9:451\u2013454","journal-title":"J Med Genet"},{"issue":"Dec 3","key":"9_CR15","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0092-8674(93)90546-3","volume":"75","author":"R Fishel","year":"1993","unstructured":"Fishel R, Lescoe MK et al (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75(Dec 3): 1027\u20131038","journal-title":"Cell"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1056\/NEJM199305063281805","volume":"328","author":"FM Giardiello","year":"1993","unstructured":"Giardiello FM, Hamilton SR et al (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328:1313\u20131316","journal-title":"N Engl J Med"},{"issue":"14","key":"9_CR17","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1056\/NEJMoa012015","volume":"346","author":"FM Giardiello","year":"2002","unstructured":"Giardiello FM, Yang VW et al (2002) Primary chemoprevention of familial adenomatous polyposis with sulindac. New England J Med 346(14):1054\u20131059","journal-title":"New England J Med"},{"issue":"10","key":"9_CR18","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1056\/NEJM199509073331001","volume":"333","author":"E Giovannucci","year":"1995","unstructured":"Giovannucci E, Egan KM et al (1995) Aspirin and the risk of colorectal cancer in women. N Engl J Med 333(10):609\u2013614","journal-title":"N Engl J Med"},{"issue":"4","key":"9_CR19","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1023\/A:1010787931002","volume":"46","author":"M Grubben","year":"2001","unstructured":"Grubben M, Braak CVD et al (2001) Effect of resistant starch on potential biomarkers for colonic cancer risk in patients with colonic adenomas: a controlled trial. Dig Dis Sci 46(4):750\u2013756","journal-title":"Dig Dis Sci"},{"issue":"35","key":"9_CR20","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.1200\/JCO.2008.17.5950","volume":"26","author":"H Hampel","year":"2008","unstructured":"Hampel H, Frankel WL et al (2008) Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 26(35):5783\u20135788","journal-title":"J Clin Oncol"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/ajmg.1320250309","volume":"25","author":"L Herrera","year":"1986","unstructured":"Herrera L, Kakati S et al (1986) Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 25:473\u2013476","journal-title":"Am J Med Genet"},{"issue":"2","key":"9_CR22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10689-011-9423-4","volume":"10","author":"K Huang","year":"2011","unstructured":"Huang K, Gutierrez LP et al (2011) Clinical characteristics and outcomes in familial adenomatous polyposis patients with a long-term treatment of celecoxib: a matched cohort study. Fam Cancer 10(2):303\u2013308","journal-title":"Fam Cancer"},{"key":"9_CR23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/ajcn\/67.1.136","volume":"67","author":"S Hylla","year":"1998","unstructured":"Hylla S, Gostner A et al (1998) Effects of resistant starch on the colon in healthy volunteers: possible implications for cancer prevention. Am J Clin Nutr 67:136\u2013142","journal-title":"Am J Clin Nutr"},{"key":"9_CR51","doi-asserted-by":"publisher","unstructured":"Jaeger E, Leedham S, Lewis A et al (2012) Hereditary mixed polyposis syndrome is caused by a 40kb upstream duplication that leads to increased and ectopic expression of the BMPantagonist GREM1 Nature Genetics Epub 6 May doi:10.1038\/ng2263","DOI":"10.1038\/ng2263"},{"issue":"7","key":"9_CR24","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/S0959-8049(02)00041-2","volume":"38","author":"JR Jass","year":"2002","unstructured":"Jass JR, Walsh MD et al (2002) Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability. Eur J Cancer 38(7):858\u2013866","journal-title":"Eur J Cancer"},{"key":"9_CR25","first-page":"4399","volume":"48","author":"GA Kune","year":"1988","unstructured":"Kune GA, Kune S et al (1988) Colorectal cancer risk, chronic illness, operations, medications: case control results from the Melbourne colorectal cancer study. Cancer Res 48:4399\u20134404","journal-title":"Cancer Res"},{"key":"9_CR26","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0016-5085(91)90519-Q","volume":"101","author":"D Labayle","year":"1991","unstructured":"Labayle D, Fischer D et al (1991) Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 101: 635\u2013639","journal-title":"Gastroenterology"},{"issue":"10","key":"9_CR27","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/jama.284.10.1297","volume":"284","author":"DR Lichtenstein","year":"2000","unstructured":"Lichtenstein DR, Wolfe MM (2000) COX-2-Selective NSAIDs. J Am Med Assoc 284(10):1297\u20131299","journal-title":"J Am Med Assoc"},{"key":"9_CR28","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/1097-0142(197106)27:6<1505::AID-CNCR2820270635>3.0.CO;2-L","volume":"27","author":"HT Lynch","year":"1971","unstructured":"Lynch HT, Krush AJ (1971) Cancer family \u201cG\u201d revisited: 1895\u20131970. ) Cancer 27: 1505\u20131511","journal-title":"Cancer"},{"issue":"6","key":"9_CR29","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/ssu.2980110607","volume":"11","author":"HT Lynch","year":"1995","unstructured":"Lynch HT, Smyrk T et al (1995) Hereditary nonpolyposis colorectal cancer and colonic adenomas: aggressive adenomas? Semin Surg Oncol 11(6):406\u2013410","journal-title":"Semin Surg Oncol"},{"issue":"4","key":"9_CR30","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/1097-0142(19950215)75:4<936::AID-CNCR2820750407>3.0.CO;2-Q","volume":"75","author":"HT Lynch","year":"1995","unstructured":"Lynch HT, Thorson AG et al (1995) Rectal cancer after prolonged sulindac chemoprevention. Cancer 75(4): 936\u2013938","journal-title":"Cancer"},{"issue":"5","key":"9_CR31","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1158\/1940-6207.CAPR-10-0319","volume":"4","author":"MA McIlhatton","year":"2011","unstructured":"McIlhatton MA, Tyler J et al (2011) Aspirin and low dose nitric oxide-donating aspirin increase life span in a lynch syndrome mouse model. Cancer Prev Res 4(5):684\u2013693","journal-title":"Cancer Prev Res"},{"key":"9_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1136\/gut.48.1.41","volume":"48","author":"SJ Mills","year":"2001","unstructured":"Mills SJ, Mathers JC et al (2001) Colonic crypt cell proliferation state assessed by whole crypt microdissection in sporadic neoplasia and familial adenomatous polyposis. GUT 48:41\u201346","journal-title":"GUT"},{"issue":"12","key":"9_CR33","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1002\/bjs.1800801244","volume":"80","author":"KP Nugent","year":"1993","unstructured":"Nugent KP, Farmer KC et al (1993) Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 80(12):1618\u20131619","journal-title":"Br J Surg"},{"issue":"9759","key":"9_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","volume":"377","author":"PM Rothwell","year":"2011","unstructured":"Rothwell PM, Fowkes FG et al (2011) Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 377(9759):31\u201341","journal-title":"Lancet"},{"issue":"9754","key":"9_CR35","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","volume":"376","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Wilson M et al (2010) Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376(9754):1741\u20131750","journal-title":"Lancet"},{"issue":"19","key":"9_CR36","doi-asserted-by":"publisher","first-page":"11301","DOI":"10.1073\/pnas.95.19.11301","volume":"95","author":"J Ruschoff","year":"1998","unstructured":"Ruschoff J, Wallinger S et al (1998) Aspirin suppresses the mutator phenotype associated with hereditary nonpolyposis colorectal cancer by genetic selection. Proc Natl Acad Sci U S A 95(19):11301\u201311306","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"9_CR37","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","volume":"342","author":"G Steinbach","year":"2000","unstructured":"Steinbach G, Lynch PM et al (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. New England J Med 342(26):1946\u20131952","journal-title":"New England J Med"},{"key":"9_CR38","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1053\/j.gastro.2008.01.015","volume":"134","author":"Y Schwitalle","year":"2008","unstructured":"Schwitalle Y, Kloor M (2008) Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. Gastroenterology 134:988-997","journal-title":"Gastroenterology"},{"key":"9_CR39","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1056\/NEJM199112053252301","volume":"325","author":"MJ Thun","year":"1991","unstructured":"Thun MJ, Namboodiri MM et al (1991) Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325:1593\u20131596","journal-title":"N Engl J Med"},{"issue":"6","key":"9_CR40","doi-asserted-by":"publisher","first-page":"e1002105","DOI":"10.1371\/journal.pgen.1002105","volume":"7","author":"IP Tomlinson","year":"2011","unstructured":"Tomlinson IP, Carvajal-Carmona LG et al (2011) Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer. PLoS Genet 7(6):e1002105","journal-title":"PLoS Genet"},{"issue":"4","key":"9_CR42","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1007\/BF02087431","volume":"39","author":"IP van Munster","year":"1994","unstructured":"van Munster IP, Tangerman A et al (1994) Effect of resistant starch on colonic fermentation, bile acid metabolism, and mucosal proliferation. Dig Dis Sci 39(4):834\u2013842","journal-title":"Dig Dis Sci"},{"issue":"Suppl 1","key":"9_CR43","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1055\/s-2007-963483","volume":"46","author":"HF Vasen","year":"2008","unstructured":"Vasen HF (2008) Can the identification of high risk groups increase the effectiveness of colon cancer screening programmes? Z Gastroenterol 46(Suppl 1):S41\u2013S42","journal-title":"Z Gastroenterol"},{"issue":"6","key":"9_CR44","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/jmg.2007.048991","volume":"44","author":"HF Vasen","year":"2007","unstructured":"Vasen HF, Moslein G et al (2007) Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet 44(6):353\u2013362","journal-title":"J Med Genet"},{"issue":"1","key":"9_CR46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1079\/PNS2002230","volume":"62","author":"EA Williams","year":"2003","unstructured":"Williams EA, Coxhead JM et al (2003) Anti-cancer effects of butyrate: use of micro-array technology to investigate mechanisms. Proc Nutr Soc 62(1):107\u2013115","journal-title":"Proc Nutr Soc"},{"issue":"3","key":"9_CR47","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/jaoac\/87.3.775","volume":"87","author":"G Young","year":"2004","unstructured":"Young G, Leu RL (2004) Resistant starch and colorectal neoplasia. J AOAC Int 87(3):775\u2013786","journal-title":"J AOAC Int"},{"issue":"4","key":"9_CR48","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/1097-0142(19950215)75:4<936::AID-CNCR2820750407>3.0.CO;2-Q","volume":"75","author":"HT Lynch","year":"1995","unstructured":"Lynch HT, Thorson AG et al (1995) Rectal cancer after prolonged sulindac chemoprevention. Cancer 75(4): 936\u2013938","journal-title":"Cancer"}],"container-title":["Recent Results in Cancer Research","Prospects for Chemoprevention of Colorectal Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-30331-9_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T07:05:47Z","timestamp":1674111947000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-30331-9_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,15]]},"ISBN":["9783642303302","9783642303319"],"references-count":48,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-30331-9_9","relation":{},"ISSN":["0080-0015"],"issn-type":[{"value":"0080-0015","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8,15]]},"assertion":[{"value":"15 August 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}